Plus Therapeutics Significantly Expands Investigational Oncology Drug Pipeline
Licenses targeted interventional radiotherapeutics platform Worldwide exclusive rights obtained for patents and next-generation technology to deliver targeted, precision radiotherapeutics for solid... | January 6, 2022
Source: marketscreener.com